86 related articles for article (PubMed ID: 20628968)
21. Soluble Tie-2 receptor levels independently predict locoregional recurrence in head and neck squamous cell carcinoma.
Homer JJ; Greenman J; Drevs J; Marme D; Stafford ND
Head Neck; 2002 Aug; 24(8):773-8. PubMed ID: 12203803
[TBL] [Abstract][Full Text] [Related]
22. Elective neck dissection during salvage surgery for locally recurrent head and neck squamous cell carcinoma after radiotherapy with elective nodal irradiation.
Dagan R; Morris CG; Kirwan JM; Werning JW; Vaysberg M; Amdur RJ; Mendenhall WM
Laryngoscope; 2010 May; 120(5):945-52. PubMed ID: 20422688
[TBL] [Abstract][Full Text] [Related]
23. [Tissue oxygen partial pressure in human head-neck carcinomas during primary radio-chemotherapy].
Jund R; Feldmann HJ; Molls M
Laryngorhinootologie; 1996 Jan; 75(1):43-7. PubMed ID: 8851119
[TBL] [Abstract][Full Text] [Related]
24. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma.
Kizilay A; Kalcioğlu MT; Ozuğurlu F; Ozyurt H; Aladağ I; Ozturan O; Akyol O
Kulak Burun Bogaz Ihtis Derg; 2007; 17(3):148-51. PubMed ID: 17873505
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of histological features in oral squamous cell carcinoma.
Larsen SR; Johansen J; Sørensen JA; Krogdahl A
J Oral Pathol Med; 2009 Sep; 38(8):657-62. PubMed ID: 19563504
[TBL] [Abstract][Full Text] [Related]
26. [Erythropoietin in patients with head and neck carcinomas?].
Schipper J; Henke M
Laryngorhinootologie; 2004 May; 83(5):292-7. PubMed ID: 15143446
[TBL] [Abstract][Full Text] [Related]
27. [Squamous cell carcinoma antigen. Current clinical value of a new tumor marker in head and neck cancer; preliminary results of a prospective study after 12 months].
Clasen B; Roettger D; Senekowitsch R; Menz E
Laryngol Rhinol Otol (Stuttg); 1988 Aug; 67(8):420-5. PubMed ID: 3210877
[TBL] [Abstract][Full Text] [Related]
28. [Current status of head and neck cancer therapy in the elderly].
Sesterhenn AM
Laryngorhinootologie; 2007 Feb; 86(2):95-100. PubMed ID: 17219330
[TBL] [Abstract][Full Text] [Related]
29. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
Arlt A; Luckhaupt H; Hildmann H
Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684
[TBL] [Abstract][Full Text] [Related]
30. [The expression of zeta-chain of the T cell receptor as prognostic marker for patients with head and neck cancer].
Müller D; Lang S; Roskrow M; Wollenberg B
Laryngorhinootologie; 2002 Jul; 81(7):516-20. PubMed ID: 12173063
[TBL] [Abstract][Full Text] [Related]
31. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
Hirakawa M; Nagai Y; Inamine M; Kamiyama K; Ogawa K; Toita T; Murayama S; Aoki Y
Gynecol Oncol; 2008 Jan; 108(1):126-9. PubMed ID: 17936344
[TBL] [Abstract][Full Text] [Related]
32. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
[TBL] [Abstract][Full Text] [Related]
33. Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neck.
Gleich LL; Gluckman JL; Nemunaitis J; Suen JY; Hanna E; Wolf GT; Coltrera MD; Villaret DB; Wagman L; Castro D; Gapany M; Carroll W; Gillespie D; Selk LM
Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):775-9. PubMed ID: 11448348
[TBL] [Abstract][Full Text] [Related]
34. Circulating and disseminated tumour cells in head and neck cancer.
Harris AT; Derbyshire S; Wilson J; Loh C; Kinshuck AJ; Attlmayr B; Jones TM
J Laryngol Otol; 2015 Sep; 129(9):826-30. PubMed ID: 26174011
[TBL] [Abstract][Full Text] [Related]
35. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
Wijffels KI; Marres HA; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH
Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286
[TBL] [Abstract][Full Text] [Related]
36. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
[TBL] [Abstract][Full Text] [Related]
37. [Alpha-fetoprotein--diagnostic utility in squamous cell carcinoma of the head and neck].
Adamiak G; Ligeziński A; Jurkiewicz D; Hermanowski M; Konieczna M
Pol Merkur Lekarski; 2001 Oct; 11(64):320-2. PubMed ID: 11770310
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
Dietl B; Marienhagen J; Schäfer C; Kölbl O
Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A
Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006
[TBL] [Abstract][Full Text] [Related]
40. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
